Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Artigo
|
![]() |
FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLCNakajima, Erica C ; Drezner, Nicole ; Li, Xiaoxue ; Mishra-Kalyani, Pallavi S ; Liu, Yajun ; Zhao, Hong ; Bi, Youwei ; Liu, Jiang ; Rahman, Atiqur ; Wearne, Emily ; Ojofeitimi, Idara ; Hotaki, Lauren Tesh ; Spillman, Dianne ; Pazdur, Richard ; Beaver, Julia A ; Singh, HarpreetClinical cancer research, 2022-04, Vol.28 (8), p.1482-1486 [Periódico revisado por pares]United StatesTexto completo disponível |
12 |
Material Type: Artigo
|
![]() |
Update of the International Consensus on Palliative Radiotherapy Endpoints for Future Clinical Trials in Bone MetastasesChow, Edward, M.B.B.S ; Hoskin, Peter, M.D ; Mitera, Gunita, Ph.D.(C) ; Zeng, Liang, B.Sc.(C) ; Lutz, Stephen, M.D ; Roos, Daniel, M.D ; Hahn, Carol, M.D ; van der Linden, Yvette, M.D ; Hartsell, William, M.D ; Kumar, Eshwar, M.B.B.SInternational journal of radiation oncology, biology, physics, 2012-04, Vol.82 (5), p.1730-1737 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
13 |
Material Type: Artigo
|
![]() |
Commentary on the EMA Guideline on strategies to identify and mitigate risks for first‐in‐human and early clinical trials with investigational medicinal productsGerven, Joop ; Bonelli, MiltonBritish journal of clinical pharmacology, 2018-07, Vol.84 (7), p.1401-1409 [Periódico revisado por pares]England: John Wiley and Sons IncTexto completo disponível |
14 |
Material Type: Artigo
|
![]() |
Phase I–II clinical trial design: a state-of-the-art paradigm for dose findingYan, F. ; Thall, P.F. ; Lu, K.H. ; Gilbert, M.R. ; Yuan, Y.Annals of oncology, 2018-03, Vol.29 (3), p.694-699 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
15 |
Material Type: Artigo
|
![]() |
A utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapiesZhou, Yanhong ; Lee, J. Jack ; Yuan, YingStatistics in medicine, 2019-12, Vol.38 (28), p.5299-5316 [Periódico revisado por pares]England: Wiley Subscription Services, IncTexto completo disponível |
16 |
Material Type: Artigo
|
![]() |
Therapeutic Antisense Oligonucleotides Are Coming of AgeBennett, C. FrankAnnual review of medicine, 2019-01, Vol.70 (1), p.307-321 [Periódico revisado por pares]United States: Annual ReviewsTexto completo disponível |
17 |
Material Type: Artigo
|
![]() |
Genome-editing Technologies for Gene and Cell TherapyMaeder, Morgan L ; Gersbach, Charles AMolecular therapy, 2016-03, Vol.24 (3), p.430-446 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
18 |
Material Type: Artigo
|
![]() |
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer ImmunotherapyPicarda, Elodie ; Ohaegbulam, Kim C ; Zang, XingxingClinical cancer research, 2016-07, Vol.22 (14), p.3425-3431 [Periódico revisado por pares]United StatesTexto completo disponível |
19 |
Material Type: Artigo
|
![]() |
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1Champiat, Stéphane ; Dercle, Laurent ; Ammari, Samy ; Massard, Christophe ; Hollebecque, Antoine ; Postel-Vinay, Sophie ; Chaput, Nathalie ; Eggermont, Alexander ; Marabelle, Aurélien ; Soria, Jean-Charles ; Ferté, CharlesClinical cancer research, 2017-04, Vol.23 (8), p.1920-1928 [Periódico revisado por pares]United States: American Association for Cancer Research IncTexto completo disponível |
20 |
Material Type: Artigo
|
![]() |
Rapid cGMP manufacturing of COVID‐19 monoclonal antibody using stable CHO cell poolsAgostinetto, Rita ; Rossi, Mara ; Dawson, Jessica ; Lim, Angela ; Simoneau, Mirva H. ; Boucher, Cyril ; Valldorf, Bernhard ; Ross‐Gillespie, Adin ; Jardine, Joseph G. ; Sok, Devin ; Burton, Dennis R. ; Hassell, Thomas ; Broly, Hervé ; Palinsky, Wolf ; Dupraz, Philippe ; Feinberg, Mark ; Dey, Antu K.Biotechnology and bioengineering, 2022-02, Vol.119 (2), p.663-666 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |